UBS AM’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-14,057
| Closed | -$1.85M | – | 2633 |
|
|
2020
Q4 | $1.85M | Buy |
14,057
+4,700
| +50% | +$618K | ﹤0.01% | 1716 |
|
|
2020
Q3 | $473K | Buy |
9,357
+5,157
| +123% | +$261K | ﹤0.01% | 2172 |
|
|
2020
Q2 | $200K | Buy |
+4,200
| New | +$200K | ﹤0.01% | 2388 |
|
|
2019
Q4 | – | Sell |
-64
| Closed | -$2.3K | – | 2919 |
|
|
2019
Q3 | $2.3K | Hold |
64
| – | – | ﹤0.01% | 2852 |
|
|
2019
Q2 | $1.99K | Buy |
+64
| New | +$1.99K | ﹤0.01% | 2828 |
|